NASDAQ: PODD - Insulet Corporation

Yield per half year: +29.17%
Sector: Healthcare

Share chart Insulet Corporation

Financial Markets by TradingView

About

Корпорация Insulet разрабатывает, производит и продает системы доставки инсулина для людей с инсулинозависимым диабетом. Он предлагает систему Omnipod, самоклеящееся одноразовое бескамерное устройство Omnipod, которое носится на теле до трех дней одновременно, а также беспроводной компаньон, портативный персональный менеджер диабета. Компания продает свою продукцию в основном через независимых дистрибьюторов и аптечные каналы, а также непосредственно в Соединенных Штатах, Канаде, Европе и на Ближнем Востоке.

More details
Корпорация Insulet была основана в 2000 году со штаб-квартирой в Актоне, штат Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/E 921.03
P/S 14.47
P/BV 140.76
EV/EBITDA 223.91
EBITDA 0.05
Цена ао 216.87
Сайт http://www.insulet.com
Число акций ао 0.07363 млрд
Выручка 0.7382
Див.доход ао 0
ISIN US45784P1012
Change price per day: +6.04% (204.42)
Change price per week: +17.15% (185.04)
Change price per month: +11.54% (194.35)
Change price per 3 month: +22.34% (177.19)
Change price per half year: +29.17% (167.82)
Change price per year: +7.51% (201.62)
Change price per 3 year: -24.71% (287.9)
Change price per 5 year: +368.19% (46.3)
Change price per year to date: +4.23% (207.97)


All parameters ⇨

Underestimation

Title Value Grade
P/S 9.38 1
P/BV 21.73 1
P/E 77.16 1
EV/EBITDA 75.98 1
Total: 3.13

Efficiency

Title Value Grade
ROA, % 8.53 3
ROE, % 34.12 9
Total: 4.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.3429

Debt

Title Value Grade
Debt/EBITDA 6.59 0
Total: 3.6

Growth impulse

Title Value Grade
Yield Revenue, % 129.96 10
Yield Ebitda, % 197.3 10
Yield EPS, % 1373.68 10
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
09.09.2024 10.09.2024 Budden Lauren
Group VP, CAO and Controller		 Sale 221.41 333 443 1506 0 0 link
09.09.2024 10.09.2024 Field Mark N
SVP & Chief Technology Officer		 Sale 220.87 305 463 1383 0 0 link
28.08.2024 29.08.2024 Field Mark N
SVP & Chief Technology Officer		 Sale 203 281 561 1387 0 0 link
28.08.2024 28.08.2024 Field Mark N
Officer		 Purchase 203 281 561 1387 0 0 link
14.06.2024 17.06.2024 Field Mark N
SVP & Chief Technology Officer		 Sale 199.96 299 940 1500 0 0 link
10.06.2024 11.06.2024 Field Mark N
SVP & Chief Technology Officer		 Sale 190.43 405 806 2131 0 0 link
10.06.2024 11.06.2024 Scannell Timothy J
Director		 Sale 190.51 1 333 570 7000 0 -0.01 link
28.05.2024 29.05.2024 Scannell Timothy J
Director		 Sale 180.9 596 970 3300 0 0 link
28.05.2024 29.05.2024 Scannell Timothy J
Director		 Purchase 32.33 590 572 18267 0 0.03 link

Institutions Volume Share, %
Capital Research Global Investors 9476623 13.55
Vanguard Group Inc 8029608 11.48
Blackrock Inc. 6102546 8.73
FMR, LLC 5873891 8.4
Wellington Management Group, LLP 3246124 4.64
State Street Corporation 2884915 4.13
Capital World Investors 2211778 3.16
Geode Capital Management, LLC 1609418 2.3
Citadel Advisors Llc 1331394 1.9
ClearBridge Investments, LLC 1327851 1.9

ETF Share, % Profitability for 1 year, % Dividends, %
First Trust Nasdaq Lux Digital Health Solutions ETF 4.56
Fidelity Digital Health ETF 3.63 0.04
Invesco S&P 500 Equal Weight Health Care ETF 1.79 0.64
SPDR S&P Health Care Equipment ETF 1.86 37.48 0.03
ALPS Disruptive Technologies ETF 1.31 30.57 0.27
Tema Obesity & Cardiometabolic ETF 3.29
Global X Telemedicine & Digital Health ETF Registered 4.63 13.62
Goldman Sachs Future Health Care Equity ETF 3.49 0.52



Head Job title Payment Year of birth
Ms. Lauren Budden Group VP, Chief Accounting Officer, Controller & Interim CFO and Treasurer N/A
Ms. Deborah R. Gordon CPA Vice President of Investor Relations N/A 1970 (54 years)
Mr. John Wodick Kapples Senior VP & General Counsel 783.36k 1960 (64 years)
Dr. James R. Hollingshead Ph.D. President, CEO & Director 2.18M 1963 (61 year)
Mr. Prem Singh Senior Vice President of Global Operations N/A 1977 (47 years)
Ms. Laetitia Cousin Senior VP of Regulatory Affairs, Quality Assurance & Compliance N/A 1976 (48 years)
Mr. Eric Benjamin Executive VP, Chief Product & Customer Experience Officer 947.57k 1983 (41 year)
Mr. Mark Field Senior VP & CTO N/A
Angela Geryak Wiczek Senior Director of Corporate Communications N/A
Mr. Philip Hildale Senior Vice President of Sales & Customer Care N/A

Address: United States, Acton, MA , 100 Nagog Park - open in Google maps, open in Yandex maps
Website: http://www.insulet.com